IL94302A - History of N-Arleic Acid (Il-Oxo) Theoxo (Pyrido] -D-3,2 [Pyridazinate - Google Patents

History of N-Arleic Acid (Il-Oxo) Theoxo (Pyrido] -D-3,2 [Pyridazinate

Info

Publication number
IL94302A
IL94302A IL9430290A IL9430290A IL94302A IL 94302 A IL94302 A IL 94302A IL 9430290 A IL9430290 A IL 9430290A IL 9430290 A IL9430290 A IL 9430290A IL 94302 A IL94302 A IL 94302A
Authority
IL
Israel
Prior art keywords
pyrido
compound
oxo
phenyl
formula
Prior art date
Application number
IL9430290A
Other languages
English (en)
Hebrew (he)
Other versions
IL94302A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL94302A0 publication Critical patent/IL94302A0/xx
Publication of IL94302A publication Critical patent/IL94302A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL9430290A 1989-05-11 1990-05-06 History of N-Arleic Acid (Il-Oxo) Theoxo (Pyrido] -D-3,2 [Pyridazinate IL94302A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/350,417 US4996204A (en) 1989-05-11 1989-05-11 Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Publications (2)

Publication Number Publication Date
IL94302A0 IL94302A0 (en) 1991-03-10
IL94302A true IL94302A (en) 1994-01-25

Family

ID=23376622

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9430290A IL94302A (en) 1989-05-11 1990-05-06 History of N-Arleic Acid (Il-Oxo) Theoxo (Pyrido] -D-3,2 [Pyridazinate

Country Status (18)

Country Link
US (1) US4996204A (fr)
EP (1) EP0401981B1 (fr)
JP (1) JPH0631235B2 (fr)
KR (1) KR920003559B1 (fr)
AT (1) ATE121743T1 (fr)
AU (1) AU611610B2 (fr)
CA (1) CA2016326C (fr)
DE (1) DE69018876T2 (fr)
DK (1) DK0401981T3 (fr)
ES (1) ES2071016T3 (fr)
FI (1) FI93013C (fr)
HU (1) HU206714B (fr)
IE (1) IE66029B1 (fr)
IL (1) IL94302A (fr)
NO (1) NO173938C (fr)
NZ (1) NZ233599A (fr)
PT (1) PT93984B (fr)
ZA (1) ZA903564B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US5716954A (en) * 1991-10-09 1998-02-10 Syntex U.S.A. Inc. Benzopyridazinone and pyridopyridazinone compounds
JP2789134B2 (ja) * 1992-09-28 1998-08-20 ファイザー・インク． 糖尿病の合併症を制御する置換ピリミジン類
GB9314412D0 (en) * 1993-07-13 1993-08-25 Rhone Poulenc Agriculture New compositions of matter
CN1205207C (zh) * 1998-03-31 2005-06-08 药品发现学会公司 取代的吲哚链烷酸
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
MXPA03004871A (es) * 2000-11-30 2003-08-19 Pfizer Prod Inc Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa.
DE60204611T2 (de) 2001-02-28 2006-05-11 Pfizer Products Inc., Groton Sulfonyl-pyridazinon-derivate zur Verwendung als Aldose-reduktase-inhibitoren
IL156462A0 (en) * 2001-03-30 2004-01-04 Pfizer Prod Inc Pyridazinone aldose reductase inhibitors
JP2004528344A (ja) * 2001-04-30 2004-09-16 ファイザー・プロダクツ・インク アルドースレダクターゼ阻害薬とシクロオキシゲナーゼ−２阻害薬の併用
AU761191B2 (en) 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) * 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
US8916563B2 (en) * 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
JP5934206B2 (ja) * 2010-07-16 2016-06-15 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク アルドース還元酵素阻害剤および同使用方法
BR112018076244A2 (pt) 2016-06-21 2019-03-26 The Trustees Of Columbia University In The City Of New York inibidores da aldose redutase e métodos de uso destes
PL3658142T3 (pl) 2017-07-28 2024-08-26 Applied Therapeutics, Inc. Związki i sposoby leczenia galaktozemii
SG11202111822QA (en) 2019-05-07 2021-11-29 Univ Miami Treatment and detection of inherited neuropathies and associated disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2708187A1 (de) * 1977-02-25 1978-08-31 Thomae Gmbh Dr K Neue pyrido-pyridazin-one
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4209527A (en) * 1979-05-16 1980-06-24 Pfizer Inc. Benzimidazolone derivatives
CA1160518A (fr) * 1979-07-06 1984-01-17 E. I. Du Pont De Nemours And Company Ustensiles de cuisson a revetement de ptfe
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof

Also Published As

Publication number Publication date
HU902996D0 (en) 1990-09-28
NO902070L (no) 1990-11-12
AU5490590A (en) 1990-11-15
PT93984B (pt) 1996-11-29
IE901701L (en) 1990-11-11
NO173938C (no) 1994-02-23
NO902070D0 (no) 1990-05-10
DK0401981T3 (da) 1995-09-04
KR920003559B1 (ko) 1992-05-04
CA2016326A1 (fr) 1990-11-11
AU611610B2 (en) 1991-06-13
EP0401981B1 (fr) 1995-04-26
CA2016326C (fr) 1995-05-30
NZ233599A (en) 1991-07-26
DE69018876D1 (de) 1995-06-01
ATE121743T1 (de) 1995-05-15
FI93013B (fi) 1994-10-31
DE69018876T2 (de) 1995-08-24
HUT54683A (en) 1991-03-28
JPH0631235B2 (ja) 1994-04-27
US4996204A (en) 1991-02-26
KR900018092A (ko) 1990-12-20
NO173938B (no) 1993-11-15
EP0401981A1 (fr) 1990-12-12
JPH035481A (ja) 1991-01-11
FI93013C (fi) 1995-02-10
IL94302A0 (en) 1991-03-10
HU206714B (en) 1992-12-28
ZA903564B (en) 1992-08-26
ES2071016T3 (es) 1995-06-16
PT93984A (pt) 1991-01-08
IE66029B1 (en) 1995-11-29
FI902335A0 (fi) 1990-05-10

Similar Documents

Publication Publication Date Title
CA2016326C (fr) Acides pyrido-pyridazinone acetiques pour traiter les complications chroniques du diabete
US4668686A (en) Imidazoquinoline antithrombrogenic cardiotonic agents
EP0252713B1 (fr) Dérivés de l'indolinone
PT98292A (pt) Processo para a preparacao de heterociclos tioxo e de composicoes farmaceuticas que os contem
US5385931A (en) Sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and application in therapeutics
US5268386A (en) Certain 3,4-dihydro 4-oxospiro [2H-1 benzopyrans] useful for treating hyperuricemia
JPH0825877B2 (ja) 眼科治療用組成物
US4940708A (en) 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts
EP0019440B1 (fr) Dérivés de la benzimidazolone, procédé pour leur préparation et compositions pharmaceutiques les contenant
CA1140928A (fr) Quinolyhydantions inhibiteurs d'aldose reductase
US4574128A (en) 5-(4-Chloro-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylic acids and their compositions having diuretic, saluretic and uricosuric activity
US4960785A (en) Indolinone derivatives
RO113856B1 (ro) Derivati ai sulfonamidei, procedee de preparare a acestora si preparate farmaceutice pentru terapia diabetului
JPH09169747A (ja) 新規置換フェニルチアゾリジン−２，４−ジオン誘導体及びその製造法
KR820001929B1 (ko) 프탈라진-4-일아세트산의 제조방법
WO1992012979A1 (fr) ACIDES ACETIQUES 2,4-DIOXO-PYRIDO [2,3-d] PYRIMIDINE-3- AINSI QUE LEURS ESTERS ET LEURS SELS
JPH08277266A (ja) スピロ三環式芳香族スクシンイミド誘導体、並びにヒト及び動物の糖尿病合併症治療剤
EP0112620A1 (fr) Hydantoines-5-(phényl substitués)
EP0160258A2 (fr) (6,11-dihydro-11-oxodibenzo[b,e]oxépinyl)-pentanols, un procédé et des intermédiaires pour leur préparation et leur emploi comme médicaments
NZ226030A (en) Spiro-azolone derivatives; pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void